| EQA 2027 - Cross Laps (CTX) |
|---|
|
Expert Biologists - Program Coordinators:
Marie LOPEZ and Laetitia SELMAN EQA performed since 2024
Number of analytical sites registered in 2026: 61 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program assesses the accuracy of the assay of one of the serum markers used in the monitoring of osteoporosis: Cross Laps (CTX), the C-terminal telopeptide of type I collagen.
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
3 – List of analytes assessed
4 – Description of the control samples
Lyophilised human control serum (samples to be resuspended in 1 mL of distilled water).
| | Legal notices and privacy policy | General terms of sale | | Last updated: 13 October 2026 | Copyright © 2011-2026 ProBioQual All rights reserved |